Showing results (201-210 of 246) with videos related to
Sort By:
Pageof 25
Journal of Medical Genetics|October 19, 2023
Loss-of-function variants in ZEB1 cause dominant anomalies of the corpus callosum with favourable cognitive prognosisSolveig Heide, Emanuela Argilli, Stéphanie Valence, et al.Clinical Genetics|August 22, 2025
Missense Variants in the Second Transmembrane Domain of TMEM17 Disrupt Its Stability and Function and Lead to a Wide Phenotypic Spectrum of CiliopathiesLucile Boutaud, Chunmei Li, Candice Moncler, et al.Journal of Medicinal Chemistry|February 5, 2026
Drug Repurposing: Conversion of the Peripherally Restricted HIV Protease Inhibitor Amprenavir to Potent, Selective, and CNS-Penetrant Agonists for the Cannabinoid Receptor 2Daniel H Haymer, Renn A Duncan, Alice L Rodriguez, et al.Elife|October 4, 2018
Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics studyChristi T Salisbury-Ruf, Clinton C Bertram, Aurelia Vergeade, et al.JACC. Basic to Translational Science|December 14, 2023
Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial HypertensionMichael S Valentine, Aaron M Bender, Sheila Shay, et al.Brain : a Journal of Neurology|November 9, 2022
Neuropathological hallmarks of antenatal mitochondrial diseases with a corpus callosum defectLucile Boutaud, Benedetta Ruzzenente, Aude Tessier, et al.ACS Chemical Neuroscience|June 23, 2026
Discovery of VU6066098: A Selective and CNS-Penetrant mGlu2 NAM with Robust Antidepressant-, Antipsychotic-, and Procognitive-like Activity in RodentsJeremy S Coleman, Rory A Capstick, Sichen Chang, et al.Molecular Pharmacology|March 5, 2022
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium ChannelsSamantha J McClenahan, Caitlin N Kent, Sujay V Kharade, et al.Brain Sciences|August 9, 2018
Clinical and Functional Characterization of the Recurrent TUBA1A p.(Arg2His) MutationJennifer F Gardner, Thomas D Cushion, Georgios Niotakis, et al.ACS Chemical Neuroscience|September 24, 2024
Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM)Julie L Engers, Logan A Baker, Sichen Chang, et al.Pageof 25